PI3K/AKT/HIF-1α

Overview

PI3K/AKT/HIF-1α refers to a signaling axis linking phosphoinositide 3-kinase (PI3K), AKT, and hypoxia-inducible factor 1-alpha (HIF-1α). In biomedical research, this pathway is widely recognized as a central regulator of cell survival, metabolism, inflammatory responses, angiogenesis, and adaptation to hypoxic stress. PI3K and AKT are upstream signaling components that can promote HIF-1α stabilization and activity, thereby influencing downstream transcriptional programs involved in glycolysis, oxidative stress responses, and tissue remodeling.

Because of these functions, PI3K/AKT/HIF-1α is frequently studied in cancer, inflammatory disease, neuroinflammation, fibrosis, and metabolic disorders. Recent work has also connected this axis with related pathways such as PI3K/Akt signaling pathway, mTOR, PTEN, SIRT1/HIF-1α pathway, and Nrf-2-SLC7A11-GSH pathway, underscoring its role as an integrative node in disease-associated metabolic reprogramming and stress adaptation.

Recent Publications Summary

Recent studies have examined PI3K/AKT/HIF-1α as a mechanistic node linking hypoxia, glycolytic reprogramming, inflammation, and tissue remodeling across several disease models. In rheumatoid arthritis-associated interstitial lung disease, Glyasperin F was reported to upregulate Sirt1 and suppress PI3K/Akt/HIF-1α signaling, which reduced glycolytic enzymes (HK2, PFK, PKM2, LDHA), lowered lactate and ATP production, and decreased oxidative stress in a murine arthritis-fibrosis model and in TGF-β1/IL-1β-stimulated MRC-5 fibroblasts; HIF-1α overexpression reversed these effects 42216775May. In acute neuroinflammation, radiofrequency electromagnetic fields and pulsed magnetic fields were investigated as neuroprotective interventions in an LPS-induced rat model, with the study specifically proposing attenuation of neuroinflammation and demyelination through PI3K/AKT/HIF-1α-mediated neurovascular protection 42183935May.

The pathway was also implicated in obesity-associated adipose tissue remodeling. Single-nucleus RNA sequencing, spatial transcriptomics, and bulk RNA-seq identified a disease-emergent adipocyte population with an end-of-trajectory signature (hEOS) in obese white adipose tissue, characterized by impaired adipokine secretion and defective insulin signaling; mechanistically, HIF1A activation under hypoxic conditions was associated with increased LAMA4 expression and niche remodeling in coordination with a macrophage subset 42107509May. In sepsis-associated encephalopathy, HIF-1α was shown to impair microglial efferocytosis by interacting with SLC7A11 and suppressing the TAM-Rac1-NCKAP1 axis; pharmacologic inhibition or stabilization of HIF-1α, together with gain- and loss-of-function approaches, was used to define this immunometabolic mechanism in BV2 cells and a CLP mouse model 41990706Apr.

Additional studies linked HIF-1α-centered metabolic signaling to inflammatory and fibrotic disease. Dunhuang Daxiefei Decoction was reported to ameliorate acute lung injury via the HIF-1α/glycolysis/H3K18la axis, consistent with a role for HIF-1α-driven glycolysis in sustaining pro-inflammatory macrophage responses 41903585Mar. In hepatocellular carcinoma, Bie-Jia-Jian Pill was investigated as a means to inhibit tumor glycolysis and promote CD8+ cell-mediated anti-tumor immunity by targeting HIF-1α-PI3K/AKT/mTOR and CCL20, highlighting the pathway’s relevance to cancer immunotherapy and the tumor microenvironment 41866005Mar.

What Changes, What Holds

1. PI3K/AKT/HIF-1α can be therapeutically suppressed to blunt glycolytic fibrosis and oxidative stress, but neuroprotection remains only proposed
NEW DIRECTION Glyasperin F extends the axis beyond its established role as a disease-associated driver by showing that inhibiting PI3K/Akt/HIF-1α can reverse a fibrotic, glycolytic, and oxidative phenotype in rheumatoid arthritis–associated lung disease 42216775May. That fits the baseline’s stress-adaptation framework, but it also suggests the pathway may be a tractable antifibrotic target in this setting. The neuroinflammation study is more tentative: it proposes PI3K/AKT/HIF-1α-mediated neurovascular protection, but does not yet settle mechanism 42183935May.

2. Hypoxia-linked HIF1A activity now appears to remodel adipose niches and to restrain microglial efferocytosis
NEW DIRECTION Obese white adipose tissue is presented as a setting where HIF1A helps define a disease-emergent adipocyte state and niche remodeling, which broadens the baseline beyond survival, metabolism, and angiogenesis into tissue architecture and cell-state emergence 42107509May. Sepsis-associated encephalopathy adds a second, distinct role: HIF-1α is implicated in impaired microglial clearance of apoptotic cells through SLC7A11-linked suppression of the TAM-Rac1-NCKAP1 axis 41990706Apr. These findings do not overturn the overview, but they expand the axis into adipose remodeling and efferocytosis.

3. HIF-1α-centered glycolysis is increasingly framed as a therapeutic lever in inflammatory lung disease and cancer immunity
REINFORCES The acute lung injury study strengthens the established view that HIF-1α drives glycolysis and inflammatory macrophage programs, because benefit tracks with dampening the HIF-1α/glycolysis axis rather than with a new mechanism 41903585Mar. The hepatocellular carcinoma work likewise reinforces the baseline by targeting HIF-1α-PI3K/AKT/mTOR to reduce tumor glycolysis and reshape the tumor microenvironment, which is exactly the kind of downstream transcriptional and metabolic control already attributed to this pathway 41866005Mar.

Overview update candidates: the new adipose-remodeling and microglial-efferocytosis roles for HIF1A; therapeutic suppression of PI3K/Akt/HIF-1α in fibrotic lung disease; HIF-1α/glycolysis as a target in acute lung injury and cancer immunotherapy.